Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 474

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 474
---
 $ |  276,000,000 | ​ | ​ |
| ​ | Plus: Remeasurement of carrying value to redemption value                 | ​ | ​ | ​ | ​ |    3,091,534 | ​ | ​ |
| ​ | Less: Shares redeemed in December 2022                                    | ​ | ​ | ​ | ​ | -263,963,913 | ​ | ​ |
| ​ | Class A common stock subject to possible redemption at December 31, 2022  | ​ | ​ | ​ | ​ |   15,127,621 | ​ | ​ |
| ​ | Less: Remeasurement of carrying value to redemption value                 | ​ | ​ | ​ | ​ |     -420,786 | ​ | ​ |
| ​ | Less: 2023 adjustment to share price for shares redeemed in December 2022 | ​ | ​ | ​ | ​ |     -298,431 | ​ | ​ |
| ​ | Less: Shares redeemed in September 2023                                   | ​ | ​ | ​ | ​ |  -10,358,754 | ​ | ​ |
| ​ | Class A common stock subject to possible redemption at December 31, 2023  | ​ | ​ | ​ | $ |    4,049,650 | ​ | ​ |

Warrants — Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class